Global Aortic and Peripheral Vascular Interventional Therapy Product Market Growth (Status and Outlook) 2026-2032
Description
The global Aortic and Peripheral Vascular Interventional Therapy Product market size is predicted to grow from US$ 10932 million in 2025 to US$ 18061 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 2032.
Aortic and Peripheral Vascular Interventional Therapy Products refer to a range of medical devices and integrated solutions used for the diagnosis and treatment of aortic and peripheral vascular diseases through minimally invasive, image-guided procedures. These products include aortic stent grafts, peripheral vascular stents, balloon catheters, guidewires and catheter systems, thrombectomy devices, and drug-coated devices. They are primarily used to treat conditions such as aortic aneurysms, aortic dissections, peripheral arterial stenosis or occlusions, and venous thrombosis. The core principle involves delivering devices precisely to target lesions via percutaneous vascular access to reconstruct vessels, exclude diseased segments, or restore blood flow. Compared with traditional open surgery, these products offer reduced trauma, faster recovery, and expanding clinical indications, representing a key evolution toward minimally invasive, precise, and integrated cardiovascular therapies.The average gross profit margin of this product is 73%.
The increasing incidence of aortic and peripheral vascular diseases, driven by aging populations and the widespread prevalence of hypertension and atherosclerosis, is supporting steady growth in interventional treatment demand. Clinical practices are shifting from open surgery to minimally invasive interventions, accelerating the adoption of endovascular aortic repair and peripheral interventions. Meanwhile, continuous advancements in stent graft technologies, low-profile delivery systems, and imaging navigation have significantly improved procedural safety and success rates. In addition, ongoing improvements in healthcare systems and rising affordability in emerging markets provide long-term growth momentum. This field is characterized by high technical complexity, with strict requirements for product design, material performance, and clinical validation, leading to long development cycles and substantial investment. Aortic intervention products, in particular, present high entry barriers, with leading multinational companies dominating the high-end segment, while local players face both technological and branding challenges. Policy factors such as centralized procurement and healthcare cost control exert pricing pressure and compress profit margins. Furthermore, complex anatomical structures and high-risk cases increase dependence on physician expertise, introducing uncertainty in clinical adoption. Clinical demand is evolving toward precision and personalization, placing higher requirements on device adaptability, long-term durability, and ease of operation. In aortic disease treatment, there is a growing trend toward early intervention and standardized management, driving demand for high-performance stent grafts. In the peripheral vascular field, greater emphasis is placed on managing long lesions and reducing restenosis. Healthcare services are gradually extending to primary care settings, increasing demand for standardized and user-friendly products. Additionally, rising needs in venous diseases and complex vascular reconstruction are driving further segmentation of product offerings. Upstream materials mainly include metallic materials, polymer materials, and biomedical coating materials, with nitinol, cobalt-chromium alloys, and polytetrafluoroethylene being key foundational materials. These materials directly determine radial strength, flexibility, and long-term stability, while also influencing biocompatibility and safety. Currently, high-end raw materials still partially rely on imports, making supply chain stability and cost control critical concerns. With advancements in material technologies and the acceleration of localization, domestic substitution is increasing, although higher requirements for quality control and manufacturing consistency are emerging.
LPI (LP Information)' newest research report, the “Aortic and Peripheral Vascular Interventional Therapy Product Industry Forecast” looks at past sales and reviews total world Aortic and Peripheral Vascular Interventional Therapy Product sales in 2025, providing a comprehensive analysis by region and market sector of projected Aortic and Peripheral Vascular Interventional Therapy Product sales for 2026 through 2032. With Aortic and Peripheral Vascular Interventional Therapy Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aortic and Peripheral Vascular Interventional Therapy Product industry.
This Insight Report provides a comprehensive analysis of the global Aortic and Peripheral Vascular Interventional Therapy Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Aortic and Peripheral Vascular Interventional Therapy Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aortic and Peripheral Vascular Interventional Therapy Product market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aortic and Peripheral Vascular Interventional Therapy Product and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aortic and Peripheral Vascular Interventional Therapy Product.
This report presents a comprehensive overview, market shares, and growth opportunities of Aortic and Peripheral Vascular Interventional Therapy Product market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stent
Catheter
Guidewire
Sheath
Vena Cava Filter
Other
Segmentation by Diseases:
Arterial Diseases
Venous Diseases
Segmentation by Material:
Metallic Devices
Polymer Devices
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
BD
Biotronik
Boston Scientific
Medtronic
Merit Medical
Terumo
Teleflex
Cook Medical
Cordis
Alvimedica
Lepu Medical
Zylox-Tonbridge Medical
Endovastec
ACOTEC
LifeTech Scientific
WEGO
Brosmed
DK MEDTECH
Barty Medical
Please note: The report will take approximately 2 business days to prepare and deliver.
Aortic and Peripheral Vascular Interventional Therapy Products refer to a range of medical devices and integrated solutions used for the diagnosis and treatment of aortic and peripheral vascular diseases through minimally invasive, image-guided procedures. These products include aortic stent grafts, peripheral vascular stents, balloon catheters, guidewires and catheter systems, thrombectomy devices, and drug-coated devices. They are primarily used to treat conditions such as aortic aneurysms, aortic dissections, peripheral arterial stenosis or occlusions, and venous thrombosis. The core principle involves delivering devices precisely to target lesions via percutaneous vascular access to reconstruct vessels, exclude diseased segments, or restore blood flow. Compared with traditional open surgery, these products offer reduced trauma, faster recovery, and expanding clinical indications, representing a key evolution toward minimally invasive, precise, and integrated cardiovascular therapies.The average gross profit margin of this product is 73%.
The increasing incidence of aortic and peripheral vascular diseases, driven by aging populations and the widespread prevalence of hypertension and atherosclerosis, is supporting steady growth in interventional treatment demand. Clinical practices are shifting from open surgery to minimally invasive interventions, accelerating the adoption of endovascular aortic repair and peripheral interventions. Meanwhile, continuous advancements in stent graft technologies, low-profile delivery systems, and imaging navigation have significantly improved procedural safety and success rates. In addition, ongoing improvements in healthcare systems and rising affordability in emerging markets provide long-term growth momentum. This field is characterized by high technical complexity, with strict requirements for product design, material performance, and clinical validation, leading to long development cycles and substantial investment. Aortic intervention products, in particular, present high entry barriers, with leading multinational companies dominating the high-end segment, while local players face both technological and branding challenges. Policy factors such as centralized procurement and healthcare cost control exert pricing pressure and compress profit margins. Furthermore, complex anatomical structures and high-risk cases increase dependence on physician expertise, introducing uncertainty in clinical adoption. Clinical demand is evolving toward precision and personalization, placing higher requirements on device adaptability, long-term durability, and ease of operation. In aortic disease treatment, there is a growing trend toward early intervention and standardized management, driving demand for high-performance stent grafts. In the peripheral vascular field, greater emphasis is placed on managing long lesions and reducing restenosis. Healthcare services are gradually extending to primary care settings, increasing demand for standardized and user-friendly products. Additionally, rising needs in venous diseases and complex vascular reconstruction are driving further segmentation of product offerings. Upstream materials mainly include metallic materials, polymer materials, and biomedical coating materials, with nitinol, cobalt-chromium alloys, and polytetrafluoroethylene being key foundational materials. These materials directly determine radial strength, flexibility, and long-term stability, while also influencing biocompatibility and safety. Currently, high-end raw materials still partially rely on imports, making supply chain stability and cost control critical concerns. With advancements in material technologies and the acceleration of localization, domestic substitution is increasing, although higher requirements for quality control and manufacturing consistency are emerging.
LPI (LP Information)' newest research report, the “Aortic and Peripheral Vascular Interventional Therapy Product Industry Forecast” looks at past sales and reviews total world Aortic and Peripheral Vascular Interventional Therapy Product sales in 2025, providing a comprehensive analysis by region and market sector of projected Aortic and Peripheral Vascular Interventional Therapy Product sales for 2026 through 2032. With Aortic and Peripheral Vascular Interventional Therapy Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aortic and Peripheral Vascular Interventional Therapy Product industry.
This Insight Report provides a comprehensive analysis of the global Aortic and Peripheral Vascular Interventional Therapy Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Aortic and Peripheral Vascular Interventional Therapy Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aortic and Peripheral Vascular Interventional Therapy Product market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aortic and Peripheral Vascular Interventional Therapy Product and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aortic and Peripheral Vascular Interventional Therapy Product.
This report presents a comprehensive overview, market shares, and growth opportunities of Aortic and Peripheral Vascular Interventional Therapy Product market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stent
Catheter
Guidewire
Sheath
Vena Cava Filter
Other
Segmentation by Diseases:
Arterial Diseases
Venous Diseases
Segmentation by Material:
Metallic Devices
Polymer Devices
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
BD
Biotronik
Boston Scientific
Medtronic
Merit Medical
Terumo
Teleflex
Cook Medical
Cordis
Alvimedica
Lepu Medical
Zylox-Tonbridge Medical
Endovastec
ACOTEC
LifeTech Scientific
WEGO
Brosmed
DK MEDTECH
Barty Medical
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
124 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Aortic and Peripheral Vascular Interventional Therapy Product Market Size by Player
- 4 Aortic and Peripheral Vascular Interventional Therapy Product by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Aortic and Peripheral Vascular Interventional Therapy Product Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
